Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04699799 · ClinicalTrials.gov registry record · NA

Characterization of Human Olfactory Amygdala Subregions

A NA study of Human Olfactory Amygdala, sponsored by Northwestern University.

Recruiting
Registry status
NA
Development phase
100
Enrollment target
1
Study location

NCT04699799 is a NA study of Human Olfactory Amygdala that is actively recruiting participants, run by Northwestern University. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04699799, a NA study of Human Olfactory Amygdala, is actively recruiting participants, sponsored by Northwestern University.

RECRUITING
Registry status
NA
Development phase
100 participants
Enrollment target
1
Study location

Study Summary

We aim to better understand the subregions of the human amygdala that receive direct projections from the olfactory bulb

Conditions Studied

Interventions

  • OTHER Present odors to participants while recording brain activity

Study Locations (1)

Illinois

  • Northwestern human olfaction lab - Chicago

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2022-01-01
Est. Completion 2026-04-01
Phase NA

Sponsor

Northwestern University

1,209 total trials

What the Registry Record Tells You About NCT04699799

The ClinicalTrials.gov registry entry for NCT04699799 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwestern University, which has 1,209 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Human Olfactory Amygdala appearing as the primary indexed condition, and to 1 intervention - of which Present odors to participants while recording brain activity is the first listed.

NCT04699799 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04699799 about?

NCT04699799 is a clinical study titled "Characterization of Human Olfactory Amygdala Subregions". We aim to better understand the subregions of the human amygdala that receive direct projections from the olfactory bulb

What is the current status of trial NCT04699799?

This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2022-01-01. Estimated completion is 2026-04-01.

What conditions does trial NCT04699799 study?

This clinical trial studies the following conditions: Human Olfactory Amygdala.

What interventions are being tested in trial NCT04699799?

The interventions under investigation include: Present odors to participants while recording brain activity (OTHER).

Who is sponsoring clinical trial NCT04699799?

This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04699799 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.